{ "ok": true, "cik": "2062583", "ticker": "MMED", "name": "MiniMed Group, Inc.", "filings": [ { "form": "10-Q", "filed": "2026-09-08", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026060926/0001628280-26-060926-index.htm" }, { "form": "8-K", "filed": "2026-09-01", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/0001628280-26-059699-index.htm" }, { "form": "DEF 14A", "filed": "2026-08-21", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000114036126034021/0001140361-26-034021-index.htm" }, { "form": "8-K", "filed": "2026-08-05", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000110465926091115/0001104659-26-091115-index.htm" }, { "form": "10-K", "filed": "2026-06-29", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026045915/0001628280-26-045915-index.htm" }, { "form": "8-K", "filed": "2026-06-29", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "5.08 Shareholder Nominations Pursuant to Rule 14a-11", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/0001104659-26-078588-index.htm" } ], "events12m": 9, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 5, "latest": { "filed": "2026-08-05", "url": "https://www.sec.gov/Archives/edgar/data/2062583/000110465926091115/0001104659-26-091115-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002062583.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062583" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up MiniMed Group, Inc. ($MMED). Last filing: 10-Q, 2026-09-08. 9 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2026-04-24", "revenue": 3102000000, "revenueGrowth1y": 0.14254143646408846, "revenueGrowthPerYear": 0.1213225223923946, "yearsOfData": 3, "operatingMargin": -0.06125080593165699, "operatingMarginPrior": -0.053775322283609574, "netMargin": -0.10735009671179883, "operatingCashFlow": -197000000, "capitalSpending": 223000000, "freeCashFlow": -420000000, "researchAndDevelopment": 448000000, "researchShareOfRevenue": 0.14442295293359123, "cash": 298000000, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2024-04-26", "revenue": 2469000000 }, { "fiscalYearEnd": "2025-04-25", "revenue": 2715000000 }, { "fiscalYearEnd": "2026-04-24", "revenue": 3102000000 } ], "totalEquity": 3611000000, "totalAssets": 4630000000, "equityRatio": 0.7799136069114471, "returnOnEquity": -0.09221822209914152, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -1.3, "sharesOutstanding": 256600000, "bookValuePerShare": 14.072486360093531, "revenuePerShare": 12.088854247856586, "range80": { "low": 2792499511.048248, "high": 4138713911.3197155, "baseline": 3511253000.1864047, "n": 4599, "band": "b1" }, "ifPaceHeld": { "low": 2792499511.048248, "high": 4138713911.3197155 } }, "edgarette": "🔖 Exposure: revenue $3.1B (FY2026). Experience: revenue up 14.3% on the year, up 12.1% a year over 2 years; operating margin -6.1%, down from -5.4%. Soundness: equity 78.0% of assets, return on equity -9.2%. Credibility: 3 audited years, moderate weight. Range: 80% of past cases like this landed between $2.8B and $4.1B next year (method v3, set from 4,599 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -6.1% against a 1.2% median; growth 14.3% against 11.6%.", "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "summary": "MiniMed Group (MMED) grew revenue 14.3% in FY2026 to $3.1 billion, operating margin -6.1% against a 1.2% median for surgical & medical instruments & apparatus, equity 78.0% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
MiniMed Group, Inc. against its own record and its peers
Operating marginPeer median 1.2%-6.1%Revenue, on the yearPeer median 11.6%14.3%Equity of assetsPeer median 52.9%78.0%Return on equityPeer median -2.3%-9.2%Gold tick: the median of 55–59 peers with $50M+ revenue in surgical & medical instruments & apparatus
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-27T22:08:43.771Z", "hash": "18902b5f133367be", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "MiniMed Group (MMED) grew revenue 14.3% in FY2026 to $3.1 billion, operating margin -6.1% against a 1.2% median for surgical & medical instruments & apparatus, equity 78.0% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2026-04-24", "revenue": 3102000000, "totalDebt": null, "cash": 298000000 }, "experience": { "revenueGrowth1y": 0.14254143646408846, "revenueGrowthPerYear": 0.1213225223923946, "operatingMargin": -0.06125080593165699, "operatingMarginPrior": -0.053775322283609574, "netMargin": -0.10735009671179883, "freeCashFlow": -420000000 }, "soundness": { "equityRatio": 0.7799136069114471, "returnOnEquity": -0.09221822209914152, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "credibility": { "auditedYears": 3, "weight": "moderate", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 5, "latest": { "filed": "2026-08-05", "url": "https://www.sec.gov/Archives/edgar/data/2062583/000110465926091115/0001104659-26-091115-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 2792499511.048248, "high": 4138713911.3197155, "baseline": 3511253000.1864047, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 4599, "sizeBand": "b1" }, "credibility": null, "stress": null, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-27T22:08:43.771Z", "hash": "18902b5f133367be", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002062583.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062583" }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0635, "growth3y": 0.1425, "volatility": 0.0271, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7971, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns -6.3% of revenue into operating cash; revenue growing 14.2% a year over three years; no common dividend.", "outside": "Among $1B-10B companies: 3rd percentile for cash, 80th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$1B-10B", "cashPctInClass": 3, "growthPctInClass": 80, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2026-04-24", "operating": -197000000, "investing": -233000000, "financing": 716000000, "capitalSpending": 223000000, "free": -420000000, "trend": [ { "fiscalYearEnd": "2024-04-26", "operating": 41000000, "free": -107000000 }, { "fiscalYearEnd": "2025-04-25", "operating": 140000000, "free": -53000000 }, { "fiscalYearEnd": "2026-04-24", "operating": -197000000, "free": -420000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2026-04-24", "cash": 298000000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 4630000000, "ladder": null, "currentRatio": 1.92, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0635, "growth3y": 0.1425, "volatility": 0.0271, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.7971, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns -6.3% of revenue into operating cash; revenue growing 14.2% a year over three years; no common dividend.", "outside": "Among $1B-10B companies: 3rd percentile for cash, 80th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$1B-10B", "cashPctInClass": 3, "growthPctInClass": 80, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2026-04-24", "operating": -197000000, "investing": -233000000, "financing": 716000000, "capitalSpending": 223000000, "free": -420000000, "trend": [ { "fiscalYearEnd": "2024-04-26", "operating": 41000000, "free": -107000000 }, { "fiscalYearEnd": "2025-04-25", "operating": 140000000, "free": -53000000 }, { "fiscalYearEnd": "2026-04-24", "operating": -197000000, "free": -420000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2026-04-24", "cash": 298000000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 4630000000, "ladder": null, "currentRatio": 1.92, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }